“HHS is ending the use of human fetal tissue from elective abortions in agency-funded research and replacing it with ...

UT Southwestern Medical Center researchers have discovered that increasing the levels of a protein called BACH2 makes ...

ST. IGNATIUS — We are entering the peak of respiratory season and are seeing increases in COVID-19 & INFLUENZA cases; Tribal ...

Discover how UCSF is leading the charge in Long COVID research, uncovering key findings that advance our understanding of the condition. UCSF researchers have adapted innovative tools and ...

You can now investigate your health worries from home, using DIY testing kits that claim to screen for a range of conditions ...

A blood test, combined with an ultrathin material derived from graphite, could significantly advance efforts to detect ...

“This gap is especially limiting in longevity research, where admixed supercentenarians may harbor unique protective variants ...

Scientists at the University College London (UCL) have developed a novel therapy that helps treat patients with T cell acute lymphoblastic leukemia (T-ALL). This form of therapy used genome editing ...

STATEN ISLAND, N.Y. — With the terrifying coronavirus (COVID-19) pandemic of 2020 behind us and the world now returned to normal, many people have moved away from vaccination or even testing for the ...

CD19-targeted CAR T-cell therapy shows a 65% response rate in Richter transformation, with median progression-free survival of 8 months and overall survival of 14.4 months. Early response and age are ...

This milestone expands patient eligibility through multi-HLA targeting Builds on completed TVGN 489 trial demonstrating 100% viral clearance, no reinfections, and no cases of Long COVID in high-risk ...